Agenda / Schedule

The Global Life Sciences Hub

Schedule
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 3

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
  • 08:30 - 08:40
  • Hall 3

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
pharma investor conference biotech - U.K.
  • 08:45 - 09:15
  • Hall 3

Collaborate or Collapse – Why Partnerships Have Become the Lifeline of Biotech Innovation

Speakers
Michael J. George

Michael J. George, CA-AM, MBA | Senior Director, Strategic Partnerships, Go To Market - Global Omnichannel | Sanofi

Sarah Tao

Sarah Tao | Search & Evaluation, Immunoglobulin (Ig) Therapeutic Area and Technologies Lead | CSL

Leena Chaudhuri

Leena Chaudhuri, PhD | Senior Director, Early Pipeline & BD, Global Medical Oncology | Merck Healthcare

Valeria Pavet

Valeria Pavet | Head of the Translational Research Unit | Cancer Research UK (CRUK)

16 Nov
pharma investor conference biotech - U.K.
  • 09:15 - 09:45
  • Hall 3

Where Biotech Value Is Being Created Today and What Buyers Are Looking For?

Speakers
Debbie Drane

Debbie Drane | Head of Business Development, Therapeutic Areas | CSL

Laura Holberger

Laura Holberger | External Innovation Partner | Novo Nordisk

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 3

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
pharma investor conference biotech - U.K.
  • 11:30 - 12:00
  • Hall 3

Rethinking Risk, Value and Deal Structures in an Increasingly Competitive Market

Speakers
Katherine Kendrick

Katherine Kendrick, CSAP | Executive Director, Head of Alliance Management | Jazz Pharmaceuticals

Pulkit Guglani

Pulkit Guglani | Director BD&L Insights and Decision Sciences | Novartis

Navin Swaroop

Navin Swaroop | Executive Director, Global Business Development, Neurology & Immunology | Merck KGaA, Darmstadt, Germany

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:-00
  • Hall 3

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 3

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 3

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 3

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 3

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
pharma investor conference biotech - U.K.
  • 08:45 - 09:15
  • Hall 3

How to get in Front of the Right Partner at the Right Time and Turning Interest into Opportunity?

Speakers
Kiichiro Yano

Kiichiro Yano, Ph.D. | Deputy Head of Research Institute Boston, Daiichi Sankyo Inc | Daiichi Sankyo, Inc

Albert Pat Fetaya

Albert "Pat" Fetaya | Partner | Princeton Global BioPharma Advisors, LLC

Nicola La Monica

Nicola La Monica | Senior Director, Strategic Search and Evaluation | Johnson & Johnson

BingLing XU

BingLing XU, PhD, MBA | Director, Business Development & Strategic Alliance (Cardiovascular-Renal-Metabolic Diseases) | Jiangsu Hengrui Pharmaceuticals Co., Ltd.

17 Nov
pharma investor conference biotech - U.K.
  • 09:15 - 09:45
  • Hall 3

Early-Stage vs. Late-Stage Assets: Where’s the Sweet Spot?

Speakers
Neeraj Kumar

Neeraj Kumar | Director, Integrated Field Targeting and NBA | Novartis

Claudia Generaux

Claudia Generaux, PhD, MBA | Director, Search and Evaluation, Strategy and Business Development | Bristol Myers Squibb

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 3

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
pharma investor conference biotech - U.K.
  • 11:30 - 12:00
  • Hall 3

Alliance & Deal Dynamics: How Big Pharma, Biotech & Partners Shape the Innovation Pipeline

Speakers
Nicole St Jean

Nicole St Jean | Executive Director, Business Development & Alliance Management | BioNTech SE

Tarun Walia

Tarun Walia | Senior Director, R&D External Innovation Pipeline Filling and Sourcing | Novo Nordisk

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 3

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 3

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 3

Keynote Presentation

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 1

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 1

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
novel drug modalities
  • 08:45 - 09:15
  • Hall 1

Target Identification in 2026: Human Genetics, Functional Genomics & Causal Biology

Speakers
Giusy Della Gatta

Giusy Della Gatta | Associate Director - Oncology/Immune - oncology | Regeneron

Ziwei Liang

Ziwei Liang | Innovation Fellow & Director, AIM² Discovery Center IMRU | Pfizer

Pichai Raman

Pichai Raman | Senior Director, Computational Biology | Incyte

Marla Weetall

Marla Weetall | Sr. Vice President, Pharmacology and Biomarkers | PTC Therapeutics

Aco Radujevic

Aco Radujević, Ph.D. | Principal Scientist, Data, Automation & Predictive Science | GSK

Jochen Schmitz

Jochen Schmitz | Executive Director, Immunology & Respiratory Disease Research | Boehringer Ingelheim

16 Nov
Bridging the Translational Gap
  • 09:15 - 09:45
  • Hall 1

Bridging the Translational Gap: From Discovery Insights to Clinical Proof

Speakers
Manfred Stapff

Manfred Stapff, MD, PhD | Clinical Development Senior Director | Pfizer

Abhirami Suresh

Abhirami Suresh | Associate Scientist, Postdoctoral Fellow | Merck

Nina Tong

Nina Tong | Senior Research Investigator, Clinical Pharmacology and Pharmacometics | Bristol Myers Squibb

Amanda Ouchida

Amanda Ouchida | Senior Scientist | Takeda

Abhijeet R Patil

Abhijeet R Patil, Ph.D. | Sr. Manager, Data Science, Translational & Precision Medicine | Teva Pharmaceuticals

Maria L. Maccecchini

Maria L. Maccecchini, PhD | Chief Executive Officer | Annovis Bio, Inc

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 1

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
advanced disease models
  • 11:30 - 12:00
  • Hall 1

Transforming Small Molecule Discovery: AI, Computational Chemistry and Predictive Science

Speakers
Deepa Korani

Deepa Korani | Machine Learning Scientist | Novo Nordisk

Aubhishek Zaman

Aubhishek Zaman, PhD | Senior Scientist | Merck

Pablo Trigo Mourino

Pablo Trigo Mouriño | Senior Principal Scientist | Pfizer

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:00 - 13:00
  • Hall 1

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:15
Company Presentation 1
12:15 – 12:30
Company Presentation 2
12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 1

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 1

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 1

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 1

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
research data integration
  • 08:45 - 09:15
  • Hall 1

From Biology to IND: Advancing Preclinical Innovation and Drug Development Strategies

Speakers
May Freag

May Freag | Associate Director | Takeda

Stella Berendam

Stella Berendam, Ph.D. | Associate Director - Immunotoxicology | Astrazeneca

Meredith Crosby

Meredith Crosby, PhD, DABT | Associate Director, Toxicology | Regeneron

Alexander Armstrong

Alexander Armstrong | Process Development Senior Scientist | Amgen

Xilu Jiao

Xilu Jiao | Director of MSRD, Otsuka-US | Otsuka Pharmaceutical Companies (U.S)

17 Nov
research data integration
  • 09:15 - 09:45
  • Hall 1

Beyond the Hype: AI's Next Frontier in Drug Development

Speakers
Matthew Clark

Matthew Clark | Vice President of Data Science | Ability Biotherapeutics

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 1

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
undruggable targets
  • 11:30 - 12:00
  • Hall 1

Tackling Undruggable Targets: Innovative Approaches and Emerging Success Stories

Speakers
Shilpa Kadam

Shilpa Kadam | Senior Director Global Translation Medicine Lead | Astellas Pharma

17 Nov
early stage research funding
  • 12:00 - 12:30
  • Hall 1

Biomarkers That Matter: From Hypothesis to Decision-Grade Evidence

Speakers
Roshanak Tolouei Semnani

Roshanak Tolouei Semnani | Executive Director Translational Research | Precigen

Anna Moore

Anna Moore Ph.D. | Principal Scientist, Pharmacology and Biomarkers | PTC Therapeutics, Inc.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 1

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 1

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 1

Keynote Presentation

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 5

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 5

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
decentralized clinical trials
  • 08:45 - 09:15
  • Hall 5

Designing High-Quality Clinical Trials: Protocol Design, Data Integrity & Regulatory Confidence

Speakers
Evelyn Guo

Evelyn Guo | Medical Director | Genmab

Paramahamsa Maturu

Paramahamsa Maturu, PhD | Associate Directorc - Clinical Development-Oncology (Clinical Science) | Daiichi Sankyo

N. Kofi Addo

N. Kofi Addo, MPH | Snr. Manager, Clinical Quality Control Oversight & Risk Management | Shionogi Inc.

Kissondra Morris

Kissondra (Mateuszczyk) Morris, MS, MBA | Associate Director: Protocol Review Committee Lead | Bristol Myers Squibb

Cindy Joanne Mazur

Cindy Joanne Mazur | Senior Clinical Research Scientist - Oncology | Genmab

Judith Inumerable

Judith Inumerable, DMSc, MBEE | Senior Director, Clinical Scientist | Syndax Pharmaceuticals

Kasturi Banerjee

Kasturi Banerjee, PhD | Senior Clinical Scientist | CSL

16 Nov
decentralized clinical trials
  • 09:15 - 09:45
  • Hall 5

Patient-Centric Clinical Trials: Designing for Recruitment, Experience & Retention

Speakers
Anu Walia

Anu Walia | Senior Clinical Operations Leader | Genentech

Mark Webb

Mark Webb, PhD | Associate Director of Clinical Research | Pentixapharm Holding AG

Ali Manouchehri

Ali Manouchehri, MD, MPH | Clinical Development Medical Director | Pfizer

Catherine A. Click

Catherine A. Click | Director, Global Head Clinical Site Payments & Participant Convenience | Vertex Pharmaceuticals

Amit Raval

Amit Raval, PhD | Director, Real World Evidence , Oncology | Bayer

Nikki Thomas

Nikki Thomas | Recruitment Strategist (Associate Director) | Pfizer

Urvi Jatania

Urvi Jatania, MS, MBA | Director, Operations Portfolio Lead | Bristol Mayers Squibb

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 5

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
patient centric clinical trials
  • 11:30 - 12:00
  • Hall 5

Optimising Clinical Trial Feasibility: Site Selection, Patient Access & Operational Readiness

Speakers
LaShell Robinson

LaShell Robinson | Executive Director, Head Global Feasibility & Trial Equity | Takeda

Angelia Drake

Angelia Drake, DNP, MSN-CRA, RN, PACS | National Director, Clinical Education | Novartis

Carla Charles

Carla Charles | Associate Director, Global Clinical Operations | Bristol Myers Squibb

Shiwani Tiwari

Shiwani Tiwari | Clinical Trial Manager | Genmab

Sherrita Dorsey

Sherrita Dorsey, MSN FNP RN | US Head Patient and Professional Advocacy | Amicus Therapeutics

16 Nov
patient centric clinical trials
  • 12:00 - 12:30
  • Hall 5

AI in Clinical Trials: Driving Operational Intelligence, Risk Management & Trial Performance

Speakers
Richard Bobek

Richard Bobek | Associate Director, Clinical Data Science | MSD

Agata Krason

Agata Krasoń, PhD | Clinical AI Scientist | Hoffmann-La Roche Ltd

Shivanjali Kumar

Shivanjali Kumar | Associate Director, Product Management | Merck

Raghav Rajagopalan

Raghav Rajagopalan | Third Party Quality Lead GCP - Director | Pfizer

Narayanarao Pavuluri

Narayanarao Pavuluri | Senior Director, Global Head of Clinical Database Services | Merck

James Kirwin

James Kirwin | COO and Sr VP, Clinical Development | SFA Therapeutics

Imran Rashid

Imran Rashid | Head Programming Center of Excellence | CSL

Nobendu Roy

Nobendu Roy | Associate Director Senior IT Business Partner - Clinical Analytics, Biostat and Data Management | Otsuka Pharmaceutical Companies (U.S.)

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 5

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 May
Keynote
  • 14:00 - 14:15
  • Hall 5

Reimagining Clinical Trials: From Sites and Systems to a Patient-First Future

Yana Matiychuk

Associate Director, Clinical Operations Program Lead

Legend Biotech

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 5

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 5

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 5

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
global clinical trials
  • 08:45 - 09:15
  • Hall 5

Accelerating Clinical Development: Optimising Trial Strategy, Efficiency & Decision-Making

Speakers
Michelle Lim-Watson

Michelle Lim-Watson | VP, Clinical Development & Program Leadership, CVD & Rare Diseases | Novo Nordisk

Haichen Yang

Haichen Yang | Vice President Of Clinical Research | Amicus Therapeutics

Amuche Anakor

Amuche Anakor MD MRCGP | Director, Clinical Development Immunology | Johnson & Johnson Innovative Medicine

Eleni Lagkadinou

Eleni Lagkadinou, MD PhD | Vice President, Head of Oncology Early Development (OED) | Abbvie

17 Nov
global clinical trials
  • 09:15 - 09:45
  • Hall 5

Strategic Partnerships in Clinical trials: Choosing the Right CROs, Vendors, and Collaborators

Speakers
Sudeesh Tantry

Sudeesh Tantry | Disease Area Head, Global Late Clinical Development | Teva Pharmaceuticals

Susan Neal

Susan Neal | Senior Director, Clinical Operations | Novavax

Mudgal Kothekar

Mudgal Kothekar | Vice President Clinical Development | Sun Pharma Advanced Research Company Ltd. (SPARC)

Celin Sabu

Celin Sabu | Associate Director Clinical Operations | Exelixis

Dennis Salotti

Dennis Salotti | Executive Director & Head Clinical Outsourcing and Site Operations | Jazz Pharmaceuticals

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 5

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
CRO partnerships
  • 12:00 - 12:30
  • Hall 5

Beyond Traditional Trials: Using RWE & Synthetic Controls to Accelerate Clinical Evidence Generation

Speakers
Anbu Damodaran

Anbu Damodaran | Associate Director, Statistical Programming | Astrazeneca

Jing Dai

Jing Dai | Director of Biostatistics, Evidence and Value Generation | Jazz Pharmaceuticals

Lauren Young

Lauren Young | Associate Director, Real-World Data Strategy, Diabetes | Novo Nordisk

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 5

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 5

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 5

Keynote Presentation

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 6

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 6

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
real world evidence
  • 08:45 - 09:15
  • Hall 6

The Evolving Role of Medical Affairs in Evidence Generation & Scientific Communication

Speakers
Stefan Kolata

Stefan Kolata | Global Medical Director | Jazz Pharmaceuticals

Rushi Potdar

Rushi Potdar, MBBS MBA | Chief Medical Officer; VP of Global Medical Affairs -Oncology Business Unit | Takeda

Thihan Padukkavidana

Thihan Padukkavidana PhD | Executive Director, Medical Affairs | Bicara Therapeutics

Peter Gin-Fu Chen

Peter Gin-Fu Chen, PhD | VP, Head of North America Medical | Biogen

Pooja Shah

Pooja Shah | Associate Director, Global Medical Affairs- Scientific Communications | Alnylam Pharmaceuticals

Jens Hildebrandt

Jens Hildebrandt | Medical Impact Lead, Executive Director Medical Affairs | Bayer

Joanne Rizzo

Joanne Rizzo | US Strategy Lead Director, Medical Affairs | Merck

16 Nov
real world evidence
  • 09:15 - 09:45
  • Hall 6

Real-World Evidence (RWE): From Data Generation to Regulatory Decision-Making

Speakers
Lidia Oliveira Saldanha e Serra

Lidia Oliveira Saldanha e Serra | Senior Director, Head Medical Affairs Emerging Affiliates | CSL

Michael J. Doane

Michael J. Doane, Ph.D. | Executive Director, Head of HEOR | Alkermes

Michelle Hillsman Sanders

Michelle Hillsman Sanders | Director, Global Regulatory Strategy | Otsuka Pharmaceutical Companies (U.S.)

Jamie Partridge Grossman

Jamie Partridge Grossman, PhD, MBA | National Director, HEOR | Bayer

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 6

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
patient engagement
  • 11:30 - 12:00
  • Hall 6

Accelerated Regulatory Pathways: FDA Strategy, Fast-Track Approvals & Global Alignment

Speakers
Adam Runkle

Adam Runkle, MRA, ML | Director, US Regulatory Intelligence and Policy | Daiichi Sankyo US

Bish Sahoo

Dr. Bish Sahoo | CMC Global Regulatory Affairs Strategy Lead | Takeda

Andrew Kelleher

Andrew Kelleher, PhD, MS, RAC | Associate Director, U.S. Regulatory Policy | Novartis

16 Nov
global regulatory compliance
  • 12:00 - 12:30
  • Hall 6

Medical Affairs as a Strategic Partner: Cross-Functional Collaboration – Strategy & Alignment

Speakers
Wendy Boivin

Wendy Boivin, PhD | Associate Director, Global Medical Strategy | CSL Seqirus

Matthew Baker

Matthew Baker, PharmD, BCMAS | Senior Medical Science Liaison | Bristol Myers Squibb

Mark Mikhail

Mark Mikhail | Director, US Medical Content Creation Strategy and Development, C3C lead | Bayer

Porsche Loring

Porsche (Wiley) Loring, PharmD | Global Medical Affairs Lead, NK LCM and PCED | Dompé

Emre Baser

Emre BAŞER, MD | Director, Medical Diagnostics | AstraZeneca

Temi Folaranmi

Temi Folaranmi | Vice President & Therapeutic Area Head, Vaccines, U.S. Medical and Clinical Affairs | GSK

Liam Lee

Liam Lee, Ph.D., MB(ASCP) | Senior Director, Medical Diagnostics - US Lung Cancer Dx Strategy Team Lead | AstraZeneca

Drew Rockett

Drew Rockett | Senior Director Medical Affairs, Insights & Analytics | Bayer

Hersh Gupta

Hersh Gupta, PharmD | Medical Science Liaison | Novartis

Lorena Griparic

Lorena Griparic, Ph.D. | Medical Science Director, General Nephrology | Biogen

Ania Siedlecki

Ania Siedlecki, MD | Associate Medical Director, CAR-T & Myeloid Hematology | Johnson & Johnson Innovative Medicine

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 6

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 6

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 6

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 6

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 6

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
medical strategy
  • 08:45 - 09:15
  • Hall 6

Scientific Narrative That Lands: Publications, Congress & KOL Strategy

Speakers
Nabil Khan

Nabil Khan, MD | Internal Medicine Medical Director | Pfizer

Samuel Fatoba

Samuel Fatoba | US Medical Affairs Head- GRC | BioMarin Pharmaceutical Inc

Stefan Kolata

Stefan Kolata | Global Medical Director | Jazz Pharmaceuticals

Jennifer Do

Jennifer Do, PharmD, MS | Associate Director, External Scientific Communications | Abbvie

Myriam Asmar

Myriam Asmar | Director, Medical Affairs – Enterprise Insights & Strategic Engagement | Novo Nordisk

Cathy Duong

Cathy Duong PharmD | Senior Director, Medical Affairs Strategy | Summit Therapeutics, Inc.

17 Nov
medical strategy
  • 09:15 - 09:45
  • Hall 6

Medical Affairs as a Strategic Partner: Cross-Functional Collaboration – Implementation & Impact

Speakers
Constance Becker

Dr. Constance Becker | Senior Patient Engagement Manager | Sobi - Swedish Orphan Biovitrum AB (publ)

Liam Lee

Liam Lee, Ph.D., MB(ASCP) | Senior Director, Medical Diagnostics - US Lung Cancer Dx Strategy Team Lead | AstraZeneca

Drew Rockett

Drew Rockett | Senior Director Medical Affairs, Insights & Analytics | Bayer

Hersh Gupta

Hersh Gupta, PharmD | Medical Science Liaison | Novartis

Lorena Griparic

Lorena Griparic, Ph.D. | Medical Science Director, General Nephrology | Biogen

Ania Siedlecki

Ania Siedlecki, MD | Associate Medical Director, CAR-T & Myeloid Hematology | Johnson & Johnson Innovative Medicine

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 6

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
digital medical affairs
  • 11:30 - 12:00
  • Hall 6

The Future of Medical Affairs: AI, Digital Engagement & Next-Generation Medical Excellence

Speakers
Marie-Ange Noue

Marie-Ange Noué, PhD, CMPP | Former Senior Director & Head of North America Scientific Communications | EMD Serono, Inc.

Cathy Duong

Cathy Duong PharmD | Senior Director, Medical Affairs Strategy | Summit Therapeutics, Inc

Shirley Ritter

Shirley Ritter PhD, MBA, BSN, BCMAS, FACMA | Senior Medical Science Liaison | AstraZeneca

17 Nov
compliance and ethics
  • 12:00 - 12:30
  • Hall 6

Digital Regulatory Transformation: AI, Automation & the Future of Compliance

Speakers
Hiroki Watarai

Hiroki Watarai, PharmD, MPA | Associate Director, Field Medical Affairs (Immunology) | Regeneron

Shabana Motlani

Shabana Motlani | Director | Novo Nordisk

Jyoti Balhara

Jyoti Balhara, PhD | Regulatory Affairs Manager | AstraZeneca

Subhayan Das

Subhayan Das | Director, Head- Business Insights & Technology, Patient Safety & Regulatory | Bristol Myers Squibb

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 6

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 6

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 6

Keynote Presentation

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 7

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 7

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
supply chain risk management
  • 09:15 - 09:45
  • Hall 7

CMC as a Value Driver: What "Ready" Looks Like by Stage

Speakers
Gautam Pangu

Gautam Pangu (PhD, PMP) | Director, Biologics CMC Project Management | Incyte

Amit Katiyar

Amit Katiyar | Senior Director- Biologics Development & Manufacturing Operations | Exelixis

Paresma Patel

Paresma (Pinky) Patel | Director, Regulatory CMC Policy and Advocacy | Gilead Sciences

Bish Sahoo

Dr. Bish Sahoo | CMC Global Regulatory Affairs Strategy Lead | TAKEDA

Manda Pasarkar

Manda Pasarkar, DTM | Global Regulatory Affairs CMC HEAD | Sanofi

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 7

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
sustainable manufacturing
  • 11:30 - 12:00
  • Hall 7

Building Resilient Pharma Supply Chains: Managing Disruption, Shortages & Global Risk Exposure

Speakers
Seif Eddine Derradji

Seif Eddine Derradji | Global Supply Chain Cross-Functional Specialist - GSC | AstraZeneca

Tom OGara

Tom O'Gara | Head of Global Supply Chain Planning | BioMarin Pharmaceutical Inc.

Amit Joshi

Amit Joshi | Senior Director, Strategic Sourcing, Supply Chain | Iovance Biotherapeutics, Inc.

Arthur L. Edge III

Arthur L. Edge III | Senior Director, Global Supply & Strategy - Respiratory & Immunology | Astrazeneca

16 Nov
advanced manufacturing tech
  • 12:00 - 12:30
  • Hall 7

Cold Chain Excellence: Enabling Cell & Gene Therapies, Vaccines & High-Value Biologics Distribution

Speakers
Eric Elbel

Eric Elbel | Logistics Director | Avidity Biosciences

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 7

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 7

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 7

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 7

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 7

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
CDMO partnerships
  • 08:45 - 09:15
  • Hall 7

Tech Transfer & Scale-Up: Reducing Risk in Clinical-to-Commercial Manufacturing Transitions

Speakers
Andy Halsey

Andy Halsey, PE | Senior Director, Biologics Manufacturing | Teva Pharmaceuticals

J. Ashley Groves

J. Ashley Groves | Director, MSAT Upstream Laboratory Lead | BioNTech SE

Nazila Miller

Nazila Miller, PhD | Director, Drug Product Development | Takeda

Cassidy Kerezsi Koch

Cassidy Kerezsi Koch | Manager, Process Technology & Manufacturing Systems | GSK

17 Nov
CDMO partnerships
  • 09:15 - 09:45
  • Hall 7

Manufacturing Excellence in Pharma: Driving Cost Efficiency, Quality Compliance & Global Scale-Up

Speakers
Sai Kiran Camsarapalli

Sai Kiran Camsarapalli | Associate Director Supply Chain Material Planning | Bristol Myers Squibb

Kedar Shewalkar

Kedar Shewalkar | Quality Digital Innovation and Delivery Lead | Associate Director | Takeda

Jeremy Peters

Jeremy Peters | Senior Manager - Cell Therapy Manufacturing Operations, Abecma | Bristol Myers Squibb

Caitlyn Stiteler

Caitlyn (Muldoon) Stiteler, MBA | Associate Director, Biologics Manufacturing | Teva Pharmaceuticals

Jared Casebeer

Jared Casebeer | Sr. Manager of External Manufacturing and CMC Lead | Immunome, Inc.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 7

Company Pitch 2

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
quality by design
  • 11:30 - 12:00
  • Hall 7

AI & Digital Supply Chains: From Demand Forecasting to Real-Time Operational Decision-Making

Speakers
Sheila Trgovac

Sheila Trgovac | Associate Director - US Supply Chain | Eli Lilly and Company

Sandeep Dhar

Sandeep Dhar | Head of Center Global Category Management (Supply Chain Procurement) | Johnson & Johnson

Suzie Rawden

Suzie Rawden | Digital Strategy & Deployment, Director | Johnson & Johnson

Karthik Narayanan

Karthik Narayanan | Sr Director of Product Management | Eli Lilly and Company

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 7

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 7

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 7

Keynote Presentation

16 Nov
manufacturing packaging registration Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 8

Conference Registration

Registration, Badge Collection, Morning Coffee.

16 Nov
manufacturing packaging chairman address
  • 08:30 - 08:40
  • Hall 8

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
patient centric sustainable packaging panel
  • 08:45 - 09:15
  • Hall 8

Market Access Strategy in a Multi-Stakeholder Environment: Aligning Evidence, Payers & Patient Access

Speakers
Silky Beaty

Silky Beaty, PharmD, MSPH | Director of Payer Value & Outcomes | Jazz Pharmaceuticals

Nazanin Mehin

Nazanin Mehin | Global Market Access and Pricing Head, Immunology | Sanofi

Harpreet Sandhu

Harpreet Sandhu | Executive Director, Market Access Cross Portfolio | Gilead Sciences

Cassaundra Johnson

Cassaundra Johnson, MSHA, RN, CMCN | Regional Payer Account Director | Organon

Valerie Mejia

Valerie Mejia | Director, US Market Access Marketing | Pfizer

Luis Hernandez

Luis Hernandez | Head, Global Health Economics & Head, US HEOR | Takeda Oncology

Melissa Hagan

Melissa Hagan, PhD, MPH | Director, US Market Access Strategic Evidence, Oncology | BeOne Medicines

16 Nov
patient centric sustainable packaging panel
  • 09:15 - 09:45
  • Hall 8

Real-World Evidence (RWE) & HEOR: Demonstrating Value for Payers, HTA Bodies & Reimbursement to Support Market Access Decisions

Speakers
Farah Jivraj

Farah Jivraj | Head, Market Access, policy and stakeholder relations | Biogen

Antonia Electra Panayi

Antonia Electra Panayi | Head, Global Medical Evidence | Takeda

Jamie Partridge Grossman

Jamie Partridge Grossman, PhD, MB | National Director, HEOR | Bayer

16 Nov
company pitch manufacturing solutions
  • 09:45 - 10:30
  • Hall 8

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
scaling biologics and advanced therapies panel
  • 11:30 - 12:00
  • Hall 8

Launch Excellence in Pharma & Biotech: Building Successful Commercialization Strategies

Speakers
Susana Guitar Jimenez

Susana Guitar Jiménez, BSC, BA, MSc, MBA, MHE | Global Market Access & Pricing Director I Biosimilars and Above Brands lead | U.S. Organon Products

Marvin Allen

Marvin Allen | Head of Trade Relations | SUN PHARMA

Vinicius Dantas Alves

Vinícius Dantas Alves | Associate Vice President & Global Brand Lead ASMD | Sanofi

Jason M. Noto

Jason M. Noto | Senior Vice President, US Market Access & Alliance Management | AVEO Oncology

Adeola Chukwumah

Adeola Chukwumah | Director Contract Strategy Oncology and Biosimilars | Pfizer

Jonny Betts

Jonny Betts | Partner | Clear View Healthcare Partners

Kevin McDermott

Kevin McDermott | Strategic Advisor & Thought Partner for Commercialization, Market Access and Program Management | American Biotech Innovation Alliance

16 Nov
shop floor to shelf alignment panel
  • 12:00 - 12:30
  • Hall 8

Navigating Reimbursement Challenges: Strategies to Improve Patient Access

Speakers
Jonah Phelps

Jonah Phelps | Area Reimbursement Lead-Southwest | Novartis

Corey Morton

Corey Morton | Field Reimbursement Manager Oncology-Urology | Johnson & Johnson Innovative Medicine

Yasmin D

Yasmin D. | Director, Global Marketing Oncology | Merck

16 Nov
company pitch packaging technologies
  • 12:30 - 13:00
  • Hall 8

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 8

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 8

Keynote Presentation

17 Nov
manufacturing packaging registration day 2
  • 07:30 - 08:30
  • Hall 8

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
chairman address day 2
  • 08:30 - 08:40
  • Hall 8

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
digital twins predictive maintenance panel
  • 08:45 - 09:15
  • Hall 8

Pricing for Innovation Under Pressure: Defending Value

Speakers
Sanket Shah

Sanket Shah, MBBS, PhD | Director, Global Value & HEOR | Jazz Pharmaceuticals

Shah Hussain

Shah Hussain | Senior Director, Market Access Strategy | Amylyx Pharmaceuticals

Jasvinder Banga

Jasvinder Banga | Associate Director, Commercial Finance | Regeneron

David T. Grace

David T. Grace | Executive Director, US General Management, Commercial Capabilities Lead (Renal Business Unit) | Novartis Pharmaceuticals

17 Nov
digital twins predictive maintenance panel
  • 09:15 - 09:45
  • Hall 8

Affordability vs Innovation: Redefining Value Through Evolving HTA & Pricing Frameworks

Speakers
Ulrich Neumann

Ulrich Neumann | Director of Access & Policy Research, J&J | Johnson & Johnson

Sara Yin

Sara (Xiaoyan) Yin | Former Global Strategic Pricing Lead | Boehringer Ingelheim

Sherrita Dorsey

Sherrita Dorsey, MSN FNP RN | US Head Patient and Professional Advocacy | Amicus Therapeutics

Kellie Murphy

Kellie Murphy | Senior Director, Ryoncil Market Access & Reimbursement | Mesoblast Limited

17 Nov
company pitch manufacturing day2
  • 09:45 - 10:30
  • Hall 8

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
serialization anti counterfeiting track trace panel
  • 11:30 - 12:00
  • Hall 8

Commercial Differentiation in Competitive Markets: Building Value Beyond Clinical Outcomes

Speakers
Vinicius Dantas Alves

Vinícius Dantas Alves | Associate Vice President & Global Brand Lead ASMD | Sanofi

Andre Spring

Andre (Berot) Spring | Vice President Global & US Marketing | Regeneron

Hachem Mahfouz

Hachem Mahfouz | Director, Immunoglobulin Franchise & Emerging Therapeutic Areas, CSL Behring | CSL Behring

Yvonne Bryant

Yvonne Bryant | Hemoglobinopathies Commercialization Head | Novo Nordisk

Vijay Iyengar

Vijay Iyengar, MD | Executive Vice President, Global Medical Affairs, Product, & Partnership Strategy | Incyte

Xiao Zhang

Xiao Zhang, PharmD, MBA | Head, Global Commercial Strategy Gastroenterology | AbbVie

17 Nov
sustainable packaging circularity panel
  • 12:00 - 12:30
  • Hall 8

AI & Digital Transformation in Commercial Strategy: Redefining Engagement, Insights & Market Performance

Speakers
Saurav Gupta

Saurav Gupta | Head of Global Digital Patient Services | Takeda

Harpreet Sandhu

Harpreet Sandhu | Executive Director, Market Access Cross Portfolio | Gilead Sciences

Teddy Sun

Teddy Sun | Director, DD&T Business Partner for Oncology Medical Affairs and Market Access | Takeda Oncology

James Shaw

James Shaw | Associate Director - Marketing Excellence | Takeda Oncology

Boris Velinov

Boris Velinov | Director, Global Marketing & Commercial Strategy | Cytokinetics

17 Nov
company pitch packaging day2
  • 12:30 - 13:00
  • Hall 8

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 8

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 8

Keynote Presentation

16 Nov
Digital Health & Diagnostics registration
  • 07:30 - 08:30
  • Hall 9

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman's Address - Digital Health
  • 08:30 - 08:40
  • Hall 9

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
Digital Health networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Digital Therapeutics Panel
  • 08:45 - 09:15
  • Hall 9

Real-World Data, Digital Biomarkers & Predictive Health Intelligence

Speakers
Arup Pramanik

Arup Pramanik MD, MSC, MBA | Head of Global RWE and HEOR Strategy, Immunology | UCB

Ranya Habash

Ranya Habash, MD | Medical Director | FDA Digital Health Network of Experts

Amy Berk

Amy Berk DNP, MSN, APRN | Frontier Industry Executive, Healthcare; Director, Population Health | Microsoft

Kal Chaudhuri

Kal Chaudhuri, MBA | Product Line Owner - Commercial Patient Advanced Analytics & AI | Sanofi

Francesco Onorati

Francesco Onorati | Director, Statistics, Quantitative Sciences, DQS, R&D | Takeda

Elayne Gordonov

Elayne Gordonov, MBA | Director, Global Digital Health Product Portfolio Lead | Takeda

16 Nov
Digital Therapeutics Panel
  • 09:15 - 09:45
  • Hall 9

Generative AI in Biopharma: Productivity Gains Without Compliance Risk

Speakers
Karan Syal

Karan Syal, PhD | Director, Commercial AI Acceleration and Innovation | Kite Pharma

Flora Nanda

Flora Nanda | Head of Data & AI | Legend Biotech

Sky Cheung

Sky Cheung, Ph.D. | Director of Clinical Development Data Science and AI | Genmab

Krishna Avva

Krishna Avva | Director, IT Architecture | Gilead Sciences

Emmanuel Akinlabi

Emmanuel Akinlabi | Associate Director - Data Science | Merck

Melissa St.Amand

Melissa St.Amand | Global Head of MSAT Digital Transformation Platform | Sanofi

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 9

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
Telehealth IoT Panel
  • 12:00 - 12:30
  • Hall 9

Remote Patient Monitoring & Decentralized Healthcare: The Future of Continuous Care

Speakers
Barbara Nollau

Barbara Nollau | Executive Director, Precision Medicine/Dx, and R&D Supplier Quality | Amgen

Kimberley Ferguson

Kimberley Ferguson | Global Head of Digital Business Architecture | Roche Diagnostics Corporation

Nikhil Khade

Nikhil Khade | Director, Digital Health | Bristol Myers Squibb

Jimish Mehta

Jimish Mehta, PharmD, MSCE | AI Platform Product Lead | Astellas Pharma

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 9

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 9

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 9

Keynote Presentation

17 Nov
Digital Health & Diagnostics registration day 2
  • 07:30 - 08:30
  • Hall 9

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman's Address Day 2 - Digital Health
  • 08:30 - 08:40
  • Hall 9

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
Digital Health networking day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Diagnostic Data Ownership Panel
  • 08:45 - 09:15
  • Hall 9

Model Validation and Governance: The New Standard for Trust

Speakers
Vamsi Tammana

Vamsi Tammana | Global Head AI Governance, IT GRC and Network Security Operations | Legend Biotech

Shams Zaman

Shams Zaman | Head of AI/ML | Acadia Pharmaceuticals

Caitlin Doyle Weiss

Caitlin Doyle Weiss | Senior Director, Enterprise AI GRC | GSK

Anubhav Srivastava

Anubhav Srivastava | Head of AI Engineering & Generative AI | Novo Nordisk

17 Nov
Diagnostic Data Ownership Panel
  • 09:15 - 09:45
  • Hall 9

Wearables & Smart Health Devices: Enabling the Future of Connected Care

Speakers
Samir Shah

Samir Shah | Director, Devices and Digital Therapeutics, CMC Regulatory Affairs | AstraZeneca

Ranya Habash

Ranya Habash, MD | Medical Director | FDA Digital Health Network of Experts

David Morra

David Morra | Head, Enabling Healthcare Technologies | CSL

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 9

Company Pitch 1

Presentations by Sponsoring Companies.

09:30 – 09:45
Company Presentation 1
09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Companion Diagnostics Panel
  • 11:30 - 12:00
  • Hall 9

AI-Powered Patient Engagement & Personalized Care: Improving Outcomes Through Digital Innovation

Speakers
Dan Eversole

Dan Eversole, PhD | Patient Health Excellence Lead (Director) | Takeda

Krishna Avva

Krishna Avva | Director, IT Architecture | Gilead Sciences

Harsha Agashe

Harsha Agashe | Head of Digital Health Portfolio Analytics | Takeda

Lauren Bataille

Lauren Bataille | Head, Digital Health Strategy | Evinova (An AstraZeneca Company)

Amy Berk

Amy Berk DNP, MSN, APRN | Frontier Industry Executive, Healthcare; Director, Population Health | Microsoft

Sudhir Shandilya

Sudhir Shandilya | Director, AI Products | Corporate Affairs, Legal & Partnering | Sanofi

Arpita Bhowmick

Arpita Bhowmick | Head of Commercial & Patient Service IT, Rare Disease Unit, US | AstraZeneca

Molly Liu

Molly Liu | Associate Director AI Data Scientist | Bristol Myers Squibb

17 Nov
Diagnostics Responsibility Panel
  • 12:00 - 12:30
  • Hall 9

AI in Drug Discovery & R&D Transformation

Speakers
Flora Nanda

Flora Nanda | Head of Data & AI | Legend Biotech

Arup Pramanik

Arup Pramanik MD, MSC, MBA | Head of Global RWE and HEOR Strategy, Immunology | UCB

Jian Zhu

Jian Zhu | Sr. Director, Innovation and Strategy Lead, Quantitative Sciences and Evidence Generation | Astellas Pharma

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 9

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 9

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 9

Keynote Presentation

16 Nov
Investment Registration
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman Address
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
Networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Valuation Panel
  • 08:45 - 09:15
  • Hall 4

What Defines an Investable Biotech Now: Team, Timing, Traction & Data

Speakers
Sarah Johnson

Sarah Johnson, Ph.D., MBA | Partner | Advantary Capital Partners

Jim Gunton

Jim Gunton | Managing Partner | Tech Council Ventures

David Berlin

David Berlin | Head of Partnerships | C10 Labs

Christiane Wherry

Christiane Wherry | Principal, Senior Investment Director | Arrow Ventures

Jimmy Melton

Jimmy Melton | Co-Founder and General Partner | Cape Fear Biocapital

Paola Torre

Paola Torre, PhD | Venture Partner | Aquillius Ventures

Vivian Mingyue Li

Vivian (Mingyue) Li, Ph.D., MBA | Early Stage Investor | K2 Bio Partners

16 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
VC Panel
  • 11:30 - 12:00
  • Hall 4

Fundraising Strategy: Pricing, Syndicates, Tranched Rounds & Extensions

Speakers
Paul Anthony Claxton

Paul Anthony Claxton | Managing Partner | Digerati Investments

Doc Parghi

Doc Parghi | Managing Partner | SRI Capital

Nate Kline

Nate Kline | Managing General Partner | Cistern Capital

Jeffrey Steckler

Jeffrey Steckler | Principal and Founder | Pontiva Healthcare Partners

Daniela Bendor

Daniela Bendor | Co-Founder & Managing Partner | IDGB Capital

Michele Washko

Michele Washko | President & CEO | Life Sciences Greenhouse Investments

16 Nov
Alternative Funding Panel
  • 12:00 - 12:30
  • Hall 4

Investor Due Diligence: Red Flags That Quietly Kill Rounds

Speakers
Ziad Sabry

Ziad Sabry | Associate | Good Growth Capital

Michael Magliochetti

Michael Magliochetti | Operating Partner | Riverside Partners

Laurent Metz

Dr Laurent Metz MD MBA | Partner | Robin Hood Ventures

Crystal Donelan

Crystal Donelan | Healthcare Investor & Advisor | HealthTech Capital

Soyoung Park

Soyoung Park | General Partner | 1004 Venture Partners

Remy Goldstein

Remy Goldstein | Partner | Venture University

Christina J. Ansted

Christina J. Ansted, MPH, CCMEP | Co-Founder and Managing Partner | RCP Venture Capital

16 Nov
Company Pitch
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 4

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 4

Keynote Presentation

17 Nov
Investment Registration Day 2
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman Address Day 2
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
Networking Day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Term Sheets Panel
  • 08:45 - 09:15
  • Hall 4

Asset, Platform, or Company: What Are Investors Backing Now?

Speakers
Marcos Villa

Marcos Villa | Principal | Escher Innovations

Brian Carlisle

Brian Carlisle, MBA | Managing Partner | Carlisle Strategic Partners

Megha Unhelkar

Megha Unhelkar, PhD | Director of Investments | Connecticut Innovations

Scott Reese

Scott Reese | Executive Board Member | M3 Group Holdings

17 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Global Capital Panel
  • 11:30 - 12:00
  • Hall 4

AI in Biotech Investment: Are Investors Backing Technology, Platforms or Clinical Proof?

Speakers
Urvashi Bhatnagar

Urvashi Bhatnagar, DPT, MBA | Managing General Partner | The Good Science Fund

Fiona Fanny Miller

Fiona (Fanny) Miller | Managing Partner | quadraScope Ventures

Gwen Cheni

Gwen Cheni | Director (Investments) | Connecticut Innovations

Alaina Percival

Alaina Percival | Venture Partner | Valor Ventures

17 Nov
Risk Mitigation Panel
  • 12:00 - 12:30
  • Hall 4

Acquisition, IPO or Independence: What Is the Optimal Exit Path for Biotech Companies?

Speakers
Jay Roberts

Jay Roberts | Partner | Ventac Partners

Alexander Dugom

Alexander Dugom | General Partner | InoSwift Capital Fund

17 Nov
Company Pitch
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 4

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 4

Keynote Presentation

16 Nov
Biologics Registration
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman Address
  • 08:30 - 08:40
  • Hall 2

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
Networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
RNA Therapeutics
  • 08:45 - 09:15
  • Hall 2

RNA Therapeutics: Unlocking the Next Wave of Medicines

Speakers
Jayharsh Panchal

Jayharsh Panchal | Director Bioanalytics | Hemab therapeutics

Zhiyi (Zoey) Zheng

Zhiyi (Zoey) Zheng | Principal Scientist, Omics Sciences, Target Discovery | GSK

16 Nov
Cell & Gene Therapy Panel
  • 09:15 - 09:45
  • Hall 2

Targeted Protein Degradation & Emerging Modalities: Expanding the Therapeutic Landscape

Speakers
Tauseef Butt

Tauseef Butt | President and CEO | Progenra

Apeksha Unnikrishnan Villath

Apeksha Unnikrishnan Villath | Scientist II, Oncology Discovery Biology | AbbVie

Johanna Mora

Johanna Mora | Executive Director of Bioanalytical Sciences | Biohaven Pharma

16 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 2

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Next-Gen Biologics Panel
  • 11:30 - 12:00
  • Hall 2

Cell & Gene Therapy Revolution: From Science to Scalable Manufacturing

Speakers
Marianna Sabatino

Marianna Sabatino | VP Process Sciences, Analytics and Technology | Astrazeneca

Yan Zhi

Yan Zhi, Ph.D. | Director, S&I Lead | CSL Behring

16 Nov
Company Pitch
  • 12:00 - 13:00
  • Hall 2

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:15
Company Presentation 1
12:15 – 12:30
Company Presentation 2
12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 2

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 2

Keynote Presentation

17 Nov
Biologics Registration Day 2
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman Address Day 2
  • 08:30 - 08:40
  • Hall 2

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
Networking Day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Next-Gen Biologics Panel
  • 08:45 - 09:15
  • Hall 2

Next-Generation Biologics: Expanding Beyond Antibodies

Speakers
Emilie Duvallet

Emilie Duvallet | Principal scientist, Immunometabolism | Novo Nordisk

Lin Huang

Lin Huang | Senior Principal Scientist | Pfizer

17 Nov
Immunotherapy Panel
  • 09:15 - 09:45
  • Hall 2

Novel Delivery Systems: LNPs, Viral Vectors & Emerging Alternatives

Speakers
Manjunatha Shivaraju

Manjunatha Shivaraju | Principal Scientist/Lab Head, Material and Analytical Science Department | Boehringer Ingelheim

Pedro J Cejas

Pedro J Cejas | Senior Director - Discovery, Delivery Platforms | Roche

Beyza Bulutoglu

Beyza Bulutoglu, Ph.D. | Senior Principal Scientist | Genentech

17 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 2

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Company Pitch
  • 12:00 - 13:00
  • Hall 2

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:15
Company Presentation 1
12:15 – 12:30
Company Presentation 2
12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 2

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 2

Keynote Presentation